AbbVie inks $1.9B deal with IGI for myeloma drug ISB 2001, a promising trispecific antibody with potential to deliver deeper, more durable responses in immuno-oncology.
UK economy contracts again amid tariffs and taxes, raising concerns about the economic outlook.
US government bars undocumented immigrants from accessing federal benefits, including Head Start, in a move to prioritize resources for US citizens.
AbbVie inks $1.9B deal with IGI for myeloma drug ISB 2001, a promising trispecific antibody with potential to deliver deeper, more durable responses in immuno-oncology.
UK economy contracts again amid tariffs and taxes, raising concerns about the economic outlook.
US government bars undocumented immigrants from accessing federal benefits, including Head Start, in a move to prioritize resources for US citizens.